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BOOK REVIEWS
Biology and Management of Lung Cancer. F.
ANTHONY GRECO, Netherlands, Martinus Nijhoff,
xiv+222 pp, 1983, $54.50.
This book is one of a series of volumes on cancer
treatment and research, and the second one in this
series on lung cancer. It concentrates largely on the
biology of the disease and is distinguished by
several excellent chapters relating to various
fundamental aspects of lung cancer. Because it has
been written by authors working very actively in
the field it is remarkably up to date and provides
excellent reviews of some topics of current major
interest.
The first three chapters discuss various aspects of
the biology of lung cancer by members of the
National Cancer Institute group studying this
problem. The first one is an excellent summary of
their very successful methods of growing and
characterising small cell lung cancer. They discuss a
variety of techniques including a serum-free
medium they have developed for growing small cell
lines and the important problem of autocrine
stimulation with the various growth factors that are
produced. The second chapter also from the same
group is a brief introduction to the possibilities of
the use of monoclonal antibodies against lung
cancer, whilst the third of the chapters, by Sherwin
and Todaro, discusses the very important subject of
transforming growth factors and their presence in
human lung cancer cells and relation to growth.
A chapter on the tumour cloning assay from San
Antonio discusses this very currently contentious
topic in a somewhat optimistic way. However it
does document the results obtained by that group
and illustrates the potential use if reproducible
techniques could be obtained. The group from
Dartmouth is responsible for another chapter which
discusses the role of the neurophysins in small cell
lung cancer, these being yet another group of
markers potentially of use.
Chapters on various aspects of therapy include
those on the role of autologous bone marrow
transplantation, the potential role of surgery in
small cell lung cancer and a brief overall review of
chemotherapy/radiotherapy in non-small cell lung
cancer. Other chapters of use include an excellent
one on the pathological diagnosis of poorly
differentiated carcinoma ofthe lung.
This book is a pleasure to read. It is fairly up to
date in an important subject which is now moving
rapidly. It is very much recommended to both those
working in the field and those who wish to find out
what is happening in current investigations in this
important subject.
N.M. Bleehen
University Department and
MRC Unit of Clinical Oncology
and Radiotherapeutics,
Addenbrooke's Hospital,
Cambridge.
Cancer of the Esophagus-Vols I and II. C.J.
PFEIFFER, USA, CRC Press, 157 pp (I), 262 pp (II),
1982 $60(I), $82(II).
These volumes contain contributions from a large
number of authors. There are six chapters on
the epidemiology of oesophageal cancer, five on
early cancer and pre-malignant lesions, four on
diagnostic methods, two brief ones on therapy and
ten on experimental oesophageal cancer. The
different chapters are rather variable in quality and
there is a great deal of overlap. It is difficult to
know just what readers this work is aimed at. The
epidemiologists and experimental workers will not
find anything new here, and the clinical sections
are too sketchy to be of much value to
gastroenterologists; but they may be interested to
learn what is going on in other disciplines. The
epidemiological studies, fascinating in themselves,
indicate that oesophageal cancer is as clear an
example of environmentally-related cancer as any;
quite simple social changes in the higher incidence
areas would certainly produce a large fall in the
numbers dying from this distressing disease.
O.G. Dodge
Dept. Pathology,
Christie Hospital & Holt Radium Institute,
Manchester.
Second International Symposium on Infections in the
Immunocompromised Host. C.S.F. EASMON & H.
GAYA, UK, Academic Press, 425 pp, £18.40, 1983,
ISBN No: 0 12 228020 2.
The Second International Symposium on Infections
in the Immunocompromised Host was held in
Stirling, Scotland, last year. The organisers aimed
to attract participants from a wide range of medical
disciplines, particularly those of surgery, oncology
and haematology, as well as specialists in
microbiology and infectious diseases. The meeting